ZA956994B - Methods for inhibiting endometrial cancer. - Google Patents

Methods for inhibiting endometrial cancer.

Info

Publication number
ZA956994B
ZA956994B ZA9506994A ZA956994A ZA956994B ZA 956994 B ZA956994 B ZA 956994B ZA 9506994 A ZA9506994 A ZA 9506994A ZA 956994 A ZA956994 A ZA 956994A ZA 956994 B ZA956994 B ZA 956994B
Authority
ZA
South Africa
Prior art keywords
methods
endometrial cancer
inhibiting endometrial
inhibiting
cancer
Prior art date
Application number
ZA9506994A
Other languages
English (en)
Inventor
Susan Margaret Boss
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA956994B publication Critical patent/ZA956994B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ZA9506994A 1994-08-22 1995-08-21 Methods for inhibiting endometrial cancer. ZA956994B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29385394A 1994-08-22 1994-08-22

Publications (1)

Publication Number Publication Date
ZA956994B true ZA956994B (en) 1997-02-21

Family

ID=23130867

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9506994A ZA956994B (en) 1994-08-22 1995-08-21 Methods for inhibiting endometrial cancer.

Country Status (17)

Country Link
EP (1) EP0777476A4 (xx)
JP (1) JPH10504824A (xx)
KR (1) KR970705387A (xx)
AU (1) AU688112B2 (xx)
CA (1) CA2198119A1 (xx)
CZ (1) CZ51897A3 (xx)
FI (1) FI970717A (xx)
HU (1) HUT76890A (xx)
IL (1) IL115022A (xx)
MX (1) MX9701327A (xx)
MY (1) MY113757A (xx)
NO (1) NO970783L (xx)
NZ (1) NZ292017A (xx)
RU (1) RU2161964C2 (xx)
TW (1) TW404834B (xx)
WO (1) WO1996005833A1 (xx)
ZA (1) ZA956994B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856340A (en) * 1995-02-28 1999-01-05 Eli Lilly And Company Method of treating estrogen dependent cancers
US6465445B1 (en) * 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
KR20160066490A (ko) * 2014-12-02 2016-06-10 주식회사 씨앤드씨신약연구소 헤테로사이클 유도체 및 그의 용도
CN115825414B (zh) * 2023-01-09 2023-04-25 中国医学科学院北京协和医院 血液或尿液代谢标志物及其在子宫内膜癌早筛中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
JPH08512197A (ja) * 1993-04-07 1996-12-24 リガンド・ファーマシューティカルズ・インコーポレーテッド 受容体アゴニストのスクリーニング方法
IL111287A0 (en) * 1993-10-15 1994-12-29 Lilly Co Eli Methods for treating resistant neoplasms
WO1996005832A1 (en) * 1994-08-22 1996-02-29 Eli Lilly And Company Methods of inhibiting primary endometrial hyperplasia
US5843964A (en) * 1994-09-22 1998-12-01 Eli Lilly And Company Methods of inhibiting endometrial mitoses

Also Published As

Publication number Publication date
AU688112B2 (en) 1998-03-05
IL115022A (en) 2000-07-31
FI970717A0 (fi) 1997-02-20
AU3370095A (en) 1996-03-14
NO970783D0 (no) 1997-02-20
MY113757A (en) 2002-05-31
CA2198119A1 (en) 1996-02-29
TW404834B (en) 2000-09-11
JPH10504824A (ja) 1998-05-12
WO1996005833A1 (en) 1996-02-29
NO970783L (no) 1997-02-20
EP0777476A1 (en) 1997-06-11
KR970705387A (ko) 1997-10-09
HUT76890A (en) 1997-12-29
EP0777476A4 (en) 1999-06-23
FI970717A (fi) 1997-02-20
RU2161964C2 (ru) 2001-01-20
MX9701327A (es) 1997-05-31
NZ292017A (en) 2000-07-28
CZ51897A3 (en) 1997-06-11
IL115022A0 (en) 1998-06-15

Similar Documents

Publication Publication Date Title
PL339911A1 (en) Transaction effecting apparatus
GB9612528D0 (en) Method for diagnosing cancer
EP0673661A3 (en) Radiotherapy system.
AU3829895A (en) Methods for treating resistant tumors
ZA963694B (en) Methods for inhibiting bone loss.
HK1018216A1 (en) New 19-nor-pregnene derivatives.
EP0675287A3 (en) Baffle for oil.
EP0664969A3 (de) Skischuh.
HK1018457A1 (en) Alkylaminobenzothiazole and-benzoxazole derivatives.
ZA976056B (en) Block former.
ZA9711567B (en) Compounds.
ZA975861B (en) Bromotiacumicin compounds.
GB9805877D0 (en) Cancer
ZA956994B (en) Methods for inhibiting endometrial cancer.
EP0685630A3 (de) Einbauvorrichtung für Doppel-Bohrrohre.
ZA956992B (en) Methods for inhibiting neuronal damage.
ZA9710349B (en) Process for making benzisothiazolin-3-ones.
ZA971167B (en) Heterocyclyl-ergoline derivatives.
CY2322B1 (en) Benzoaeguequinoline derivatives.
ZA979404B (en) Aspirinate compounds.
ZA969923B (en) Antioxidant.
AU2813797A (en) Method for diagnosing cancer
ZA977904B (en) Valve apparatus.
GB9420615D0 (en) Oilfield operations
ZA987390B (en) Methods for preventing headaches.